Delivery Order SPE2DB24D1104-SPE2DB25FYAN6

Award Date 5/1/25
Potential Completion Date 5/2/25
Potential Value $54K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,364.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the supply of Cosentyx Unoready 300 mg pen, a medication used to treat certain medical conditions. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $12,806.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx Unoready 300 mg pen 2 ml. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award, valued at $15,459.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Cosentyx Unoready 300 mg pen, a specialty medication. The contract has a firm fixed price and an ultimate completion date of November 6, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,254.05 firm fixed-price delivery order is for the supply of 4565700164 Cosentyx Unoready 300 mg pen 2 ml, a specialty medication. The contract has a completion date of September 6, 2024 and was awarded on September 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,274.76 firm fixed-price delivery order is to provide Cosentyx Unoready 300 mg pens to support the DLA's medical supply needs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,525.01 firm fixed-price contract is for the delivery of Cosentyx Unoready 300 mg pen injectors. The award is associated with a $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order for the supply of Cosentyx Unoready 300 mg pen (2 ml) to the DLA Troop Support Medical program, which supports the Department of Defense. The contract has a ceiling value of $9,131.70 and a period of performance through April 30, 2024....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,260.99, is for the delivery of Cosentyx Unoready 300 mg Pen 2 ml medication. This is a firm fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract was awarded on April 11, 2025 and does not have a set-aside designation. AmerisourceBergen holds a...
This federal contract award, valued at $18,055.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cosentyx Unoready 300 mg Pen 2 ml, a specialty medication, with an ultimate completion date of October 16, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $9,447.36 for the delivery of a specialty medication, Cosentyx unoready 300 mg pen 2 ml. The contract has a period of performance through December 12, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FYAN6
    Delivery Order

This federal contract award, valued at $53,640.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Cosentyx Unoready 300 mg pen, a prescription medication, over the period ending on May 2, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs and other government agencies through December 2026.

Generated 7/31/25, 10:20 AM